ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 3,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $19.18, for a total transaction of $57,540.00. Following the completion of the transaction, the chief executive officer now owns 162,000 shares of the company's stock, valued at $3,107,160. This trade represents a 1.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
ReposiTrak Trading Down 2.1%
Shares of ReposiTrak stock traded down $0.40 during trading on Wednesday, hitting $19.04. The stock had a trading volume of 58,618 shares, compared to its average volume of 43,838. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.03 and a current ratio of 6.03. ReposiTrak Inc. has a 12 month low of $14.23 and a 12 month high of $25.01. The stock has a market cap of $348.05 million, a P/E ratio of 57.18 and a beta of 0.54.
ReposiTrak Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Investors of record on Monday, June 30th will be given a dividend of $0.0182 per share. This represents a $0.07 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend is Monday, June 30th. ReposiTrak's payout ratio is 20.59%.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Get Our Latest Stock Report on TRAK
Hedge Funds Weigh In On ReposiTrak
A hedge fund recently raised its stake in ReposiTrak stock. Ellsworth Advisors LLC lifted its holdings in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,289 shares of the company's stock after purchasing an additional 2,997 shares during the quarter. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 at the end of the most recent quarter. 27.35% of the stock is owned by institutional investors.
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
